Floatz logo

Therapeutic Asset Ratings

18,140 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Muamycin
Peritoneal Carcinomatosis
H. Lee Moffitt Cancer Center and Research InstituteP4B (62)
Nepenthe
Breast Cancer
Antalya Training and Research HospitalP4B (62)
Neurotop
Neuralgia
Karbala UniversityP4B (62)
Ondansetron
Chronic Pain Syndrome
Tianjin Medical University General HospitalP4B (62)
Ondansetron
Morbid Obesity
Tanta UniversityP4B (62)
Oxygen
Anxiety Disorder
Beth Israel Deaconess Medical CenterP4B (62)
Oxygen
Prostate Disorder
Beth Israel Deaconess Medical CenterP4B (62)
Oxygen
Major Depressive Disorder
Women's College HospitalP4B (62)
Pazopanib
Breast Carcinoma
University Medical Center GroningenP4B (62)
PBR28
Multiple Sclerosis
Massachusetts General HospitalP4B (62)
Pravastatin
Cardiovascular Disorder
McMaster UniversityP4B (62)
Pregabalin
Post-Operative Pain, Non-Human Animal
Medical University of WarsawP4B (62)
Propofol
Depressive Disorder
Min SuP4B (62)
Propofol
Parkinson Disease
Nyree PennP4B (62)
Rifaximin
Metabolic Dysfunction-Associated Steatotic Liver Disease
Shanghai Changzheng HospitalP4B (62)
Rifaximin
Portal Hypertension
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)P4B (62)
Ropivacaine
Chronic Pain Syndrome
Biobizkaia Health Research InstituteP4B (62)
Sevoflurane
Chronic Pain Syndrome
Nantes University HospitalP4B (62)
Simvastatin
Transient Ischemic Attack
Prof. dr. Nathalie van der VeldeP4B (62)
Sirolimus
Skin Squamous Cell Carcinoma
Dana-Farber Cancer InstituteP4B (62)
Sitagliptin
Metabolic Dysfunction-Associated Steatotic Liver Disease
University Health Network, TorontoP4B (62)
Sufentanyl
Scoliosis
Peking University First HospitalP4B (62)
Tapentadol
Chronic Pain Syndrome
University of ThessalyP4B (62)
Tapentadol
Neuralgia
Aretaieion University HospitalP4B (62)
Temsirolimus
Non-Hodgkin Lymphoma
Canadian Cancer Trials GroupP4B (62)
Showing 3101 to 3125 of 18,140 assets
PreviousPage 125 of 726Next